Cargando…
Correction to: Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683452/ https://www.ncbi.nlm.nih.gov/pubmed/29132354 http://dx.doi.org/10.1186/s12933-017-0608-5 |
| _version_ | 1783278282143170560 |
|---|---|
| author | Hayashi, Toshiyuki Fukui, Tomoyasu Nakanishi, Noriko Yamamoto, Saki Tomoyasu, Masako Osamura, Anna Ohara, Makoto Yamamoto, Takeshi Ito, Yasuki Hirano, Tsutomu |
| author_facet | Hayashi, Toshiyuki Fukui, Tomoyasu Nakanishi, Noriko Yamamoto, Saki Tomoyasu, Masako Osamura, Anna Ohara, Makoto Yamamoto, Takeshi Ito, Yasuki Hirano, Tsutomu |
| author_sort | Hayashi, Toshiyuki |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5683452 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-56834522017-11-20 Correction to: Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin Hayashi, Toshiyuki Fukui, Tomoyasu Nakanishi, Noriko Yamamoto, Saki Tomoyasu, Masako Osamura, Anna Ohara, Makoto Yamamoto, Takeshi Ito, Yasuki Hirano, Tsutomu Cardiovasc Diabetol Correction BioMed Central 2017-11-13 /pmc/articles/PMC5683452/ /pubmed/29132354 http://dx.doi.org/10.1186/s12933-017-0608-5 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Correction Hayashi, Toshiyuki Fukui, Tomoyasu Nakanishi, Noriko Yamamoto, Saki Tomoyasu, Masako Osamura, Anna Ohara, Makoto Yamamoto, Takeshi Ito, Yasuki Hirano, Tsutomu Correction to: Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin |
| title | Correction to: Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin |
| title_full | Correction to: Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin |
| title_fullStr | Correction to: Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin |
| title_full_unstemmed | Correction to: Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin |
| title_short | Correction to: Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin |
| title_sort | correction to: dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683452/ https://www.ncbi.nlm.nih.gov/pubmed/29132354 http://dx.doi.org/10.1186/s12933-017-0608-5 |
| work_keys_str_mv | AT hayashitoshiyuki correctiontodapagliflozindecreasessmalldenselowdensitylipoproteincholesterolandincreaseshighdensitylipoprotein2cholesterolinpatientswithtype2diabetescomparisonwithsitagliptin AT fukuitomoyasu correctiontodapagliflozindecreasessmalldenselowdensitylipoproteincholesterolandincreaseshighdensitylipoprotein2cholesterolinpatientswithtype2diabetescomparisonwithsitagliptin AT nakanishinoriko correctiontodapagliflozindecreasessmalldenselowdensitylipoproteincholesterolandincreaseshighdensitylipoprotein2cholesterolinpatientswithtype2diabetescomparisonwithsitagliptin AT yamamotosaki correctiontodapagliflozindecreasessmalldenselowdensitylipoproteincholesterolandincreaseshighdensitylipoprotein2cholesterolinpatientswithtype2diabetescomparisonwithsitagliptin AT tomoyasumasako correctiontodapagliflozindecreasessmalldenselowdensitylipoproteincholesterolandincreaseshighdensitylipoprotein2cholesterolinpatientswithtype2diabetescomparisonwithsitagliptin AT osamuraanna correctiontodapagliflozindecreasessmalldenselowdensitylipoproteincholesterolandincreaseshighdensitylipoprotein2cholesterolinpatientswithtype2diabetescomparisonwithsitagliptin AT oharamakoto correctiontodapagliflozindecreasessmalldenselowdensitylipoproteincholesterolandincreaseshighdensitylipoprotein2cholesterolinpatientswithtype2diabetescomparisonwithsitagliptin AT yamamototakeshi correctiontodapagliflozindecreasessmalldenselowdensitylipoproteincholesterolandincreaseshighdensitylipoprotein2cholesterolinpatientswithtype2diabetescomparisonwithsitagliptin AT itoyasuki correctiontodapagliflozindecreasessmalldenselowdensitylipoproteincholesterolandincreaseshighdensitylipoprotein2cholesterolinpatientswithtype2diabetescomparisonwithsitagliptin AT hiranotsutomu correctiontodapagliflozindecreasessmalldenselowdensitylipoproteincholesterolandincreaseshighdensitylipoprotein2cholesterolinpatientswithtype2diabetescomparisonwithsitagliptin |